New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis

Human Molecular Genetics

Volumn 23, Issue 13, 2014, Pages 3506-3512

  Valle, Laura ^a   Hernández Illán, Eva ^b   Bellido, Fernando ^a   Aiza, Gemma ^a   Castillejo, Adela ^c   Castillejo, María Isabel ^c   Navarro, Matilde ^a   Seguí, Nuria ^a   Vargas, Gardenia ^a   Guarinos, Carla ^b   Juarez, Miriam ^b   Sanjuán, Xavier ^d   Iglesias, Silvia ^a   Alenda, Cristina ^b   Egoavil, Cecilia ^b   Segura, Ángel ^e   Juan, María José ^f   Rodriguez Soler, María ^b   Brunet, Joan ^g   González, Sara ^a   Jover, Rodrigo ^b   Lázaro, Conxi ^a   Capellá, Gabriel ^a   Pineda, Marta ^a   Soto, José Luís ^c   Blanco, Ignacio ^a   more..

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c Elche University Hospital   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f Valencian Autonomous Government   (Spain)

^g CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DNA DIRECTED DNA POLYMERASE BETA; DNA DIRECTED DNA POLYMERASE DELTA; DNA DIRECTED DNA POLYMERASE DELTA 1; K RAS PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; UNCLASSIFIED DRUG; DNA DIRECTED DNA POLYMERASE ALPHA; DNA DIRECTED DNA POLYMERASE GAMMA; POLD1 PROTEIN, HUMAN; POLE PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER STAGING; EXON; FAMILIAL COLON POLYPOSIS; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE SEQUENCE; GENETIC COUNSELING; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GERMLINE MUTATION; HEREDITARY COLORECTAL CANCER; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; ONCOGENE N RAS; ONSET AGE; PRIORITY JOURNAL; COLON POLYPOSIS; COLORECTAL TUMOR; GENETICS; MIDDLE AGED;

ADENOMATOUS POLYPOSIS COLI; ADULT; COLORECTAL NEOPLASMS; DNA POLYMERASE II; DNA POLYMERASE III; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED;

EID: 84902330508     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu058     Document Type: Article

References (23)

1. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
2. Aaltonen, L., Johns, L., Jarvinen, H., Mecklin, J.P. and Houlston, R. (2007) Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin. Cancer Res., 13, 356-361.
3. Abdel-Rahman,W.M.and Peltomaki, P. (2008)Lynchsyndromeand related familial colorectal cancers. Crit. Rev. Oncog., 14, 1-22; discussion 23-31.
4. Lynch, H.T., Lynch, P.M., Lanspa, S.J., Snyder, C.L., Lynch, J.F. and Boland, C.R. (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin. Genet., 76, 1-18.
5. Sieber, O.M., Lipton, L., Crabtree, M., Heinimann, K., Fidalgo, P., Phillips, R.K., Bisgaard, M.L., Orntoft, T.F., Aaltonen, L.A., Hodgson, S.V. et al. (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N. Engl. J. Med., 348, 791-799.
6. Jaeger, E., Leedham, S., Lewis, A., Segditsas, S., Becker, M., Cuadrado, P.R., Davis, H., Kaur, K., Heinimann, K., Howarth, K. et al. (2012) Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat. Genet., 44, 699-703.
7. Howe, J.R., Sayed, M.G., Ahmed, A.F., Ringold, J., Larsen-Haidle, J., Merg, A., Mitros, F.A., Vaccaro, C.A., Petersen, G.M., Giardiello, F.M. et al. (2004) The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J. Med. Genet., 41, 484-491.
8. Beggs, A.D., Latchford, A.R., Vasen, H.F., Moslein, G., Alonso, A., Aretz, S., Bertario, L., Blanco, I., Bulow, S., Burn, J. et al. (2010) Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut, 59, 975-986.
9. Mester, J. and Eng, C. (2013) When overgrowth bumps into cancer: the PTEN-opathies. Am. J. Med. Genet. C Semin. Med. Genet., 163, 114-121.
10. Palles, C., Cazier, J.B., Howarth, K.M., Domingo, E., Jones, A.M., Broderick, P., Kemp, Z., Spain, S.L., Guarino, E., Salguero, I. et al. (2013) Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat. Genet., 45, 136-144.
11. Donehower, L.A., Creighton, C.J., Schultz, N., Shinbrot, E., Chang, K., Gunaratne, P.H., Muzny, D., Sander, C., Hamilton, S.R., Gibbs, R.A. et al. (2013) MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. J. Pathol., 229, 99-110.
12. Church, D.N., Briggs, S.E., Palles, C., Domingo, E., Kearsey, S.J., Grimes, J.M., Gorman, M., Martin, L., Howarth, K.M., Hodgson, S.V. et al. (2013) DNA polymerase epsilon and delta exonuclease domain mutations in endometrial cancer. Hum. Mol. Genet., 22, 2820-2828.
13. Briggs, S. and Tomlinson, I. (2013) Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers. J. Pathol., 230, 148-153.
14. Murphy, K., Darmawan, H., Schultz, A., Fidalgo da Silva, E. and Reha-Krantz, L.J. (2006) A method to select for mutator DNA polymerase deltas in Saccharomyces cerevisiae. Genome, 49, 403-410.
15. Smith, C.G., Naven, M., Harris, R., Colley, J., West, H., Li, N., Liu, Y., Adams, R., Maughan, T.S., Nichols, L. et al. (2013) Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer. Hum. Mutat., 34, 1026-1034.
16. Hes, F.J., Nielsen, M., Bik, E.C., Konvalinka, D., Wijnen, J.T., Bakker, E., Vasen, H.F., Breuning, M.H. and Tops, C.M. (2008) Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut, 57, 71-76.
17. Kirk, R. (2013) Genetics: new classification for endometrial cancer puts genes in POLE position. Nat. Rev. Clin. Oncol., 10, 304.
18. Gomez-Fernandez, N., Castellvi-Bel, S., Fernandez-Rozadilla, C., Balaguer, F., Munoz, J., Madrigal, I., Mila, M., Grana, B., Vega, A., Castells, A. et al. (2009) Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations? BMC Med. Genet., 10, 57.
19. Guarinos, C., Sanchez-Fortun, C., Rodriguez-Soler, M., Perez-Carbonell, L., Egoavil, C., Juarez, M., Serradesanferm, A., Bujanda, L., Fernandez-Banares, F., Cubiella, J. et al. (2013) Clinical subtypes and molecular characteristics of serrated polyposis syndrome. Clin. Gastroenterol. Hepatol., 11, 705-711; quiz e746.
20. Yue, P. and Moult, J. (2006) Identification and analysis of deleterious human SNPs. J. Mol. Biol., 356, 1263-1274.
21. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server for predicting damaging missense mutations. Nat. Methods, 7, 248-249.
22. Ng, P.C. and Henikoff, S. (2002) Accounting for human polymorphisms predicted to affect protein function. Genome Res., 12, 436-446.
23. Gonzalez-Perez, A. and Lopez-Bigas, N. (2011) Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am. J. Hum. Genet., 88, 440-449.